11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: A single center experience over 11 years

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2423-2432

  Yamamoto, Shinji ^a,c   Hellman, Per ^a   Wassberg, Cecilia ^a   Sundin, Anders ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3 O METHYLDOPAMINE; ADRENALIN; CHROMOGRANIN A; HYDROXYEPHEDRINE C 11; METADRENALIN; NORADRENALIN; NORMETADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SIPPLE SYNDROME; THYROIDECTOMY;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; EFFICIENCY; EPHEDRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84863595048     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3342     Document Type: Article

References (22)

1. Bravo EL 1994 Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356-368 (Pubitemid 24180793)
2. Ilias I, Pacak K 2005 Diagnosis and management of tumors of the adrenal medulla. Horm Metab Res 37:717-721 (Pubitemid 43028071)
3. Shulkin BL, Ilias I, Sisson JC, Pacak K 2006 Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann NY Acad Sci 1073:374-382 (Pubitemid 44912032)
4. Sundin A, Garske U, Orlefors H 2007 Nuclear imaging of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21:69-85 (Pubitemid 46421900)
5. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M 2006 Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298-302 (Pubitemid 43905318)
6. Hammarstedt L, Muth A, Wängberg B, Björneld L, Sigurjónsdóttir HA, Götherström G, Almqvist E, Widell H, Carlsson S, Ander S, Hellström M 2010 Adrenal lesion frequency: a prospective, crosssectional CT study in a defined region, including systematic re-evaluation. Acta Radiol 51:1149-1156
7. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP 2009 Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) 8:163-184
8. Park BK, Kim CK, Kwon GY, Kim JH 2007 Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 17:2804-2809 (Pubitemid 47603975)
9. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F 2007 Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14:935-956 (Pubitemid 351252428)
10. Bravo EL, Tagle R 2003 Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539-553 (Pubitemid 37056243)
11. Ilias I, Pacak K 2009 Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome. Endocr Regul 43:89-93
12. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC 1999 Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology 212:35-41 (Pubitemid 29302508)
13. Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K 2007 Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25:2262-2269 (Pubitemid 46954653)
14. Sundin A, Sörensen J, Orlefors H, Eriksson B, Bergström M, Fasth K, Långström B 1999 Whole-body PET with [11C]-5- hydroxytryptophan for localization of neuroendocrine tumors. Clin Positron Imaging 2:338
15. Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP 2009 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I- metaiodobenzylguanidinescintigraphy, computed tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 94:3922-3930
16. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B, Pacak K 2003 Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidinescintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083-4087 (Pubitemid 37153702)
17. Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A, Adams KT, Pacak K 2009 Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf) 71:11-17
18. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K 2009 Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94:4757-4767
19. Shulkin BL, Wieland DM, Schwaiger M, Thompson NW, Francis IR, Haka MS, Rosenspire KC, Shapiro B, Sisson JC, Kuhl DE 1992 PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 33:1125-1131
20. Trampal C, Engler H, Juhlin C, Bergström M, Langström B 2004 Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 230:423-428 (Pubitemid 38133802)
21. Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA 2006 [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann Surg Oncol 13:187-197 (Pubitemid 43157413)
22. Shulkin BL, Wieland DM, Baro ME, Ungar DR, Mitchell DS, Dole MG, Rawwas JB, Castle VP, Sisson JC, Hutchinson RJ 1996 PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 37:16-21 (Pubitemid 26125958)